FDA 483 - Quotient Sciences - Philadelphia, LLC - December 22, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
The FDA inspected Quotient Sciences - Philadelphia, LLC, a drug manufacturer, and found deficiencies in their equipment cleaning and sanitization practices. The firm failed to conduct updated clean equipment hold time studies for new major manufacturing equipment and lacked formal justification for worst-case swab sampling locations in cleaning validation studies. These issues indicate potential risks to the safety, identity, strength, quality, or purity of drug products.
ID · 9687b827-63ce-4b8f-a9cb-3405520bccb7